drugset / Trial / NCT01095679

Baclofen and Hypoxia-induced Periodic Ventilation

NCT01095679

Phase 1 Completed 53 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedCrossoverDouble-blindTreatment

Summary

Periodic ventilation that includes CHEYNE Stokes ventilation is a pathological pattern characterized by alternating periods of hyperpneas and apnea-hypopneas. It occurs generally during sleep, at high altitude and in hypoxic conditions in healthy subjects, and in some diseases like congestive heart failure. One study conducted on an animal model suggested that baclofen, a drug already used against spasticity in humans, could also be effective against periodic ventilation. The goal of the study is therefore to assess this hypothesis on hypoxia-induced periodic ventilation in healthy subjects during sleep.

Timeline

Start
2010-03
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Baclofen Small molecule 20 mg